Phathom Pharmaceuticals Responds to FDA Docket on VOQUEZNA
Phathom Pharmaceuticals reacts to FDA's public docket on VOQUEZNA's exclusivity, amid ongoing litigation with BDR Pharmaceuticals.
Elme Communities to Delist from NYSE Amid Liquidation Plans
Elme Communities is set to delist from the NYSE due to low stock prices and will begin trading OTC as it moves forward with liquidation plans.
Bio Essence Corp adds new directors, amends bylaws
Bio Essence Corp appoints Thea Zhang and Geoff Fellows to its board, expanding governance and operational capabilities while amending bylaws for a larger board.
Eikon Therapeutics presents clinical data at oncology congress
Eikon Therapeutics shares promising clinical data from its PARP1 and WRN helicase programs at the European Society for Medical Oncology Congress.
ENB Financial Corp Reports Strong Q3 2026 Earnings Growth
ENB Financial Corp announces a 16.8% rise in Q3 net income, reflecting successful integration of Cecil Bancorp and robust loan growth.
Stewart Information Services reports Q3 2026 financial results
Stewart Information Services Corp reports Q3 2026 results, showing revenue growth but a decline in net income amid industry challenges.
Consumer Portfolio Services Reports Strong Q3 2026 Results
Consumer Portfolio Services, Inc. announces impressive Q3 results with significant growth in net income and loan origination, impacting the finance services sector.
Oak Valley Bancorp reports strong Q3 results with higher income
Oak Valley Bancorp announces increased net income and improved margins for Q3 2026, reflecting strong operational performance in the state commercial banking sector.
Eagle Bancorp Reports Q3 2026 Results, Declares Dividend
Eagle Bancorp, Inc. announces significant Q3 2026 results with increased net income and a cash dividend, reflecting strategic growth in the commercial banking sector.
Ionis Pharmaceuticals Reports Positive Phase 3 Results for Sefaxersen
Ionis Pharmaceuticals announces a 43.1% reduction in proteinuria with sefaxersen, a potential treatment for IgA nephropathy, based on Phase 3 study results.
Federal Home Loan Bank of Boston Elects Four New Directors
Federal Home Loan Bank of Boston announces election of four new directors effective January 1, 2027, alongside updated compensation policies.
Procaccianti Hotel REIT modifies loan, extends maturity date
Procaccianti Hotel REIT, Inc. modifies loan terms to increase borrowing capacity and extends maturity date, supporting renovations at Hotel Indigo.
Zymeworks Enters Major Collaboration with Roche for ZW209
Zymeworks has signed a collaboration agreement with Roche, granting exclusive rights to develop ZW209, a promising cancer treatment, with significant financial incentives.
UY Scuti Acquisition Corp. Enters Merger Agreement with Isdera
UY Scuti Acquisition Corp. announces a merger with Isdera Group Limited, a significant step in the blank check industry.
Cognition Therapeutics Gains FDA Alignment for Phase 3 Trial
Cognition Therapeutics announces FDA alignment on its Phase 3 trial for zervimesine, a treatment for dementia with Lewy bodies.
Worthington Steel's Kloeckner Agreement Fails Shareholder Vote
Worthington Steel's proposed agreement with Kloeckner fails to gain shareholder approval, impacting future strategies and operational plans.
Federal Home Loan Bank of Boston Reports Q3 Results, Declares Dividend
Federal Home Loan Bank of Boston reports Q3 net income of $66.4 million and declares a 6.72% dividend, emphasizing its strong financial health.
Innventure, Inc. Faces Delisting from Nasdaq Due to Bid Price
Innventure, Inc. is at risk of delisting from Nasdaq after failing to meet the minimum bid price requirement, highlighting challenges in the blank check sector.
Healthcare Triangle approves reverse stock split measures
Healthcare Triangle, Inc. stockholders approve reverse stock splits to stabilize share price and comply with Nasdaq regulations.
Tompkins Financial reports Q3 results, announces dividend increase
Tompkins Financial Corp reports a 21% rise in Q3 net income and announces a dividend increase, signaling strong performance in the banking sector.